SCHEMBL6649963

SCHEMBL6649963

CCC(C(=O)O)c1cccc(Oc2ccc(C#N)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.51
AKR1C3 P42330 4/20 0.48
AKR1C2 P52895 4/20 0.48
AKR1C1 Q04828 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP2D6 P10635 1/20 0.47
FNTA P49354 1/20 0.46
FNTB P49356 1/20 0.46
ALOX5 P09917 1/20 0.45
EGLN2 Q96KS0 4/20 0.44
EGLN1 Q9GZT9 4/20 0.44
PARP15 Q460N3 1/20 0.43
PARP10 Q53GL7 1/20 0.43
PARP2 Q9UGN5 1/20 0.43
POLB P06746 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11565294 0.88 AKR1C3 (0.50) PTGS1AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL5110019 0.86 PTGS1 (0.67) PTGS1AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL14762502 0.82 GRM4 (0.48) PTGS1AKR1C3AKR1C2AKR1C1
SCHEMBL2474521 0.79 GAA (0.48) PTGS1AKR1C3AKR1C2AKR1C1MAPT
SCHEMBL2020322 0.78 AKR1C3 (0.70) PTGS1AKR1C3AKR1C2AKR1C1KDM4E
SCHEMBL507026 0.78 CYP19A1 (0.47) PTGS1MEN1KMT2ACYP2D6FNTA
SCHEMBL14280733 0.77 PTGS1 (0.51) PTGS1AKR1C3AKR1C2AKR1C1MEN1
Water SCHEMBL11762220 0.76 PTGS1 (0.54) PTGS1AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL28575917 0.76 PTGS1 (0.56) PTGS1AKR1C3AKR1C2AKR1C1MEN1
SCHEMBL22889052 0.75 CYP19A1 (0.45) PTGS1MEN1KMT2ACYP2D6FNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762188-B1 INHIBITING THYMIDYLATE SYNTHASE; COLON, BREAST OR LUNG CARCINOMA SMITHKLINE BEECHAM CORPORATION 2004-07-13 US disclosed
EP-1199307-B1 Pharmaceutically active benzoquinazoline compounds WELLCOME FOUND (GB) 2004-02-25 EP disclosed
EP-1199307-A1 Pharmaceutically active benzoquinazoline compounds THE WELLCOME FOUNDATION LIMITED (GB) 2002-04-24 EP disclosed
US-6306865-B1 SYNTHASE INHIBITORS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. 2001-10-23 US disclosed
US-6090941-A Pharmaceutically active benzoquinazoline compounds GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
US-5663337-A ENZYME, ANTITUMOR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
US-5661155-A THYMIDYLATE SYNTHASE INHIBITOR; ADMINISTERING TO THE MAMMAL SUFFERING FROM LEUKEMIA OR TUMOR 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLINE-9-YL) METHYL)AMINO)-1-OXO-2-ISOINDOLINYL)GLUTARIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1997-08-26 US disclosed
US-5405851-A Administering benzoquinazoline thymidylate synthase inhibitors BURROUGHS WELLCOME CO. (US) 1995-04-11 US disclosed
WO-1991019700-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-26 WO disclosed